Health Condition 1: F333- Major depressive disorder, recurrent, severe with psychotic symptoms
Conditions
Interventions
Intervention1: PROPOFOL: Injection Propofol i/v 2mg/kg over120 seconds
Control Intervention1: ETOMIDATE: Injection Etomidate I/v 0.2 mg/kg over 120 seconds
Sponsors
Pacific Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients relative given consent 2 ASA GRADE I AND II 3 Age range Adults aged 18 years to 50 years 4 ECT Indication Patients diagnosed with psychiatric conditions for which ECT is indicated
Exclusion criteria
Exclusion criteria: 1 Patients relative refusal 2 ASA Grade more than 2 3 Known Allergy Patients with a known allergy or adverse reaction to study drug 4 Severe Cardiovascular Disorders Individuals with severe uncontrolled cardiovascular conditions e.g unstable angina recent myocardial infarction 5 Pregnancy and Lactation Pregnant or Lactating women 6 Epilepsy 7 Neuromuscular disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| For better knowledge of how patients respond to propofol and etomidate before, during and after Electro Convulsive Therapy (ECT) in order to better comprehend the anesthetic impact.Timepoint: 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To report any adverse effectsTimepoint: 24 months | — |
Countries
India
Contacts
Public ContactDr Nishtha Goel
Pacific Medical College and Hospital
Outcome results
None listed